TITLE:
Study of FK463 for the Treatment of Invasive Aspergillosis

CONDITION:
Aspergillosis

INTERVENTION:
FK463

SUMMARY:

      The purpose of the study is to evaluate the safety and efficacy of FK463 in patients with
      proven or probable invasive infections due to Aspergillus species.
    

DETAILED DESCRIPTION:

      This will be an open-label, non-comparative study of intravenous FK463. Enrollment will
      include at least 100 patients evaluable for efficacy.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria

          -  Has proven or probable systemic infection with Aspergillus species

        Exclusion Criteria

          -  Has abnormal liver test parameters, e.g., AST or ALT > 10 times upper limit of normal

          -  Has bronchopulmonary aspergillosis, aspergillomas, sinus aspergillosis or external
             otitis but does not have histologic evidence of tissue invasion

          -  Has life-expectancy judged to be less than 5 days
      
